These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1976354)

  • 1. Bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma.
    Vose JM; Armitage JO; Bierman PJ
    Cancer Treat Res; 1990; 50():259-78. PubMed ID: 1976354
    [No Abstract]   [Full Text] [Related]  

  • 2. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
    Langenmayer I; Weaver C; Buckner CD; Lilleby K; Appelbaum FR; Longin K; Rowley S; Storb R; Singer J; Bensinger WI
    Bone Marrow Transplant; 1995 Feb; 15(2):241-6. PubMed ID: 7773213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
    Michelson JD; Gornet M; Codd T; Torres J; Lanighan K; Jones R
    Exp Hematol; 1993 Mar; 21(3):475-82. PubMed ID: 8440346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
    Mendoza E; Territo M; Schiller G; Lill M; Kunkel L; Wolin M
    Bone Marrow Transplant; 1995 Feb; 15(2):299-303. PubMed ID: 7773222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
    Kessinger A; Nademanee A; Forman SJ; Armitage JO
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):577-87. PubMed ID: 1972701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for the treatment of refractory malignancies.
    Decter JA; Bekele W; Ahmed T
    N J Med; 1993 Apr; 90(4):307-9. PubMed ID: 8506093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
    Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for Hodgkin's disease and lymphoma.
    Vose JM; Armitage JO
    Annu Rev Med; 1993; 44():255-63. PubMed ID: 8476247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation.
    Conlan MG; Haire WD; Lieberman RP; Lund G; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1991 Mar; 7(3):235-40. PubMed ID: 1676322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation following high-dose busulfan and VP-16 for advanced non-Hodgkin's lymphoma and Hodgkin's disease.
    Rosenfeld CS; Przepiorka D; Schwinghammer TL; Buck DS; Bloom EJ; Shadduck RK
    Exp Hematol; 1991 Jun; 19(5):317-21. PubMed ID: 2026183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
    Cioch M; Jawniak D; Kotwica K; Wach M; Mańko J; Gorący A; Klimek P; Mazurkiewicz E; Jarosz P; Hus M
    Transplant Proc; 2014 Oct; 46(8):2882-4. PubMed ID: 25380941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center].
    Rio B; Marjanovic Z; Belhocine R; Vekhoff A; Andrieu V; Klaren J; Boccaccio C; Delmer A; Ajchenbaum-Cymbalista F; Hunault M; Bazarbachi A; Lévy V; Andreu G; Zittoun R
    Ann Med Interne (Paris); 1996; 147(5):313-9. PubMed ID: 9033732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous bone marrow transplantation for the treatment of malignant lymphoma in adults].
    Da WM; Zhong JT; Huang YS
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):640-2, 660. PubMed ID: 1582346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the effectiveness of hematopoietic cell mobilization with chemotherapy and filgrastim versus filgrastim alone for autologous transplant in patients with lymphoma.].
    Gutiérrez-Aguirre CH; De la Garza-Salazar F; Cantú-Rodríguez O; González-Llano Ó; Jaime-Pérez JC; Mancias-Guerra C; García-Sepúlveda R; Salazar-Riojas R; Gómez-Almaguer D
    Gac Med Mex; 2016 Oct; 152(Suppl 2):57-65. PubMed ID: 27792717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly discovered quick, non-invasive screening method of bone marrow malignancies including various leukemias, Hodgkin's lymphoma, non-Hodgkin's lymphoma, & multiple myeloma by abnormality of small rectangular area within bone marrow organ representation areas of the face.
    Omura Y; O'Young B; Jones M; Nihrane A; Duvvi H; Paluch K; Shimotsuura Y; Ohki M
    Acupunct Electrother Res; 2012; 37(1):13-47. PubMed ID: 22852211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors.
    Ketterer N; Espinouse D; Chomarat M; Dumontet C; Moullet I; Rieux C; Neidhardt-Berard EM; Bouafia F; Coiffier B; Salles G
    Am J Med; 1999 Feb; 106(2):191-7. PubMed ID: 10230749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY.
    Avalos BR; Klein JL; Kapoor N; Tutschka PJ; Klein JP; Copelan EA
    Bone Marrow Transplant; 1993 Aug; 12(2):133-8. PubMed ID: 8401359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation (ABMT) in poor prognosis diffuse non-Hodgkin's lymphomas (NHL). Report of Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
    Coser P; Santini G; Rizzoli V; Porcellini A; Chisesi T; Sertoli R; Contu A; Salvagno L; Vinante O; Rossi E
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():164. PubMed ID: 2697432
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma.
    Armitage JO
    Bone Marrow Transplant; 1992; 10 Suppl 1():62-3. PubMed ID: 1521093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.